Sponsor or institution

Clinical trials and research at Vega Therapeutics, Inc

• 2Clinical trials
• 12Countries

All recruiting trials (2)

• Subcutaneous VGA039 to prevent bleeds in people with von Willebrand disease

  This study will test whether subcutaneous VGA039 can reduce bleeding in people aged 12–75 with any type of von Willebrand disease who have frequent bleeds.

  Recruiting at 32 sites Phase 3 Vega Therapeutics, Inc · Little Rock, Arkansas and 31 other locations · NCT07115004

• Evaluating VGA039 in Healthy Volunteers and Patients with Von Willebrand Disease

  This study is testing a new treatment called VGA039 to see if it is safe and effective for healthy people and those with von Willebrand Disease.

  Recruiting at 24 sites Phase 1/2 Vega Therapeutics, Inc · Los Angeles, California and 24 other locations · NCT05776069

Quick answers

How many clinical trials run by Vega Therapeutics, Inc are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in Australia (2 trials), Austria (2 trials), Brazil (2 trials), South Africa (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →